Disclosure statement
J. B. M. received honoraria from Abbvie, Jazz Pharmaceuticals, and Astellas. S. D. B. received honoraria from Agios, Celgene, Forma Therapeutics, Abbvie, Astellas, Daichi, Novartis, Pfizer and Jazz Pharmaceuticals and has received research funding from Agios and Forma Therapeutics. C. M. received honoraria from Astellas. W. C. received personal fee from Qiagen. P. H. received honoraria from Novartis Pharma, Amgen and non-financial support from Novartis Pharma, Amgen, Celgene, Janssen-Cilag and Roche.
The other authors (J. P., B. S. P., J. E. M., S. C., S. K. H., F. S., F. P., C. W., M. L., A. B. A., O. B., O. C., C. C. L., S. C., C. B., V. S., N. A., P. F., R. B., J. C. M., I. P., and C. B. C.) declare no potential competing interests.